The use of human nasal in vitro cell systems during drug discovery and development

被引:89
作者
Dimova, S
Brewster, ME
Noppe, M
Jorissen, A
Augustijns, P
机构
[1] Catholic Univ Louvain, Lab Pharmacotechnol & Biopharm, B-3000 Louvain, Belgium
[2] Johnson & Johson Pharmaceut Res & Dev, Div Janssen Pharmaceut A, B-2340 Beerse, Belgium
[3] Katholieke Univ Leuven, Lab Expt Otorhinolaryngol, B-3000 Louvain, Belgium
关键词
nasal cell cultures; primary cultures; cell culture methodology; ciliary beat frequency;
D O I
10.1016/j.tiv.2004.07.003
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The nasal route is widely used for the administration of drugs for both topical and systemic action. At an early stage in drug discovery and during the development,process, it is essential to gain a thorough insight of the nasal absorption potential, metabolism and toxicity of the active compound and the components of the drug formulation. Human nasal epithelial cell cultures may provide a reliable screening tool for pharmaco-toxicological assessment of potential nasal drug formulations. The aim of this review is to give an overview of the information relevant for the development of a human nasal epithelial cell culture model useful during drug discovery and development. A primary goal in the development of in vitro cell culture systems is to maintain differentiated morphology and biochemical features, resembling the original tissue as closely as possible., The potential and limitations of the existing in vitro human nasal models are summarized. The following topics related to cell culture methodology are discussed: (i) primary cultures versus cell lines; (ii) cell-support substrate; (iii) medium and medium supplements; and (iv) the air-liquid interface model versus liquid-liquid. Several considerations with respect to the use of in vitro systems for pharmaceutical applications (transport, metabolism, assessment of ciliary toxicity) are also discussed. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:107 / 122
页数:16
相关论文
共 105 条
[1]   In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved [J].
Agu, R ;
Dang, HV ;
Jorissen, M ;
Willems, T ;
Vandoninck, S ;
Van Lint, J ;
Vandenheede, JV ;
Kinget, R ;
Verbeke, N .
PHARMACEUTICAL RESEARCH, 2003, 20 (08) :1125-1132
[2]  
Agu RU, 2002, STP PHARMA SCI, V12, P81
[3]  
Agu RU, 2002, STP PHARMA SCI, V12, P13
[4]  
Agu RU, 1999, PHARMACEUT RES, V16, P1380
[5]   Safety assessment of selected cyclodextrins - effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis [J].
Agu, RU ;
Jorissen, M ;
Willems, T ;
Van den Mooter, G ;
Kinget, R ;
Verbeke, N ;
Augustijns, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 193 (02) :219-226
[6]   In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies [J].
Agu, RU ;
Jorissen, M ;
Willems, T ;
Augustijns, P ;
Kinget, R ;
Verbeke, N .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (11) :1447-1456
[7]  
AGU RU, 2001, BIOCONCEPTS, V7, P1
[8]  
ANDERSEN I, 1983, EUR J RESPIR DIS, V64, P37
[9]  
BAEZASQUIBAN A, 1994, IN VITRO CELL DEV-AN, V30A, P56
[10]   Effects of physicochemical properties and other factors on systemic nasal drug delivery [J].
Behl, CR ;
Pimplaskar, HK ;
Sileno, AP ;
deMeireles, J ;
Romeo, VD .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (1-2) :89-116